Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Macular Diseases

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

J Clin Med

Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group

doi: 10.3390/jcm14072370

Glaucoma and Ocular Pressure

Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change

Am J Ophthalmol

Hallaj S, Halfpenny W, Chuter BG, Weinreb RN, Baxter SL, Cui QN

doi: 10.1016/j.ajo.2024.08.030

Macular Diseases

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study

Int J Retina Vitreous

Grimaldi G, Cancian G, Paris A, Clerici M, Volpe G, Menghini M

doi: 10.1186/s40942-024-00586-w

Further Publications

Short-Term Ocular Biometric Changes as Predictors of Long-Term Angle Closure Progression

JAMA Ophthalmol

Hong KL, Xu BY, Wang W, Cho A, Kistler NM, Foster PJ, Jiang Y, Aung T, Friedman DS, He M

doi: 10.1001/jamaophthalmol.2025.1007

Macular Diseases

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

Ophthalmol Ther

Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group

doi: 10.1007/s40123-024-00983-2

Glaucoma and Ocular Pressure

Long-term Safety and Performance of a Suprachoroidal Pressure Sensor System: Results of the EYEMATE-SC Trial Follow-Up Study

Ophthalmology

Micheletti E, Mansouri K, Dick HB, Hoffmann EM, Mackert MJ, Weinreb RN, Szurman P, EYEMATE-SC study group

doi: 10.1016/j.ophtha.2025.01.021

Surgery and InterventionFurther Publications

Association of intravitreal and topical anti-inflammatory therapies on short-term anatomical and functional outcomes following epiretinal membrane surgery

Acta Ophthalmol

Sutinen P, Hecht I, Karesvuo M, Jeon S, Karesvuo P, Tuuminen R

doi: 10.1111/aos.17430

Macular DiseasesFurther Publications

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients

Am J Ophthalmol

Ghezala IB, Gabrielle PH, Sibert M, Steinberg LA, Dautriche A, Arnould L, Creuzot-Garcher C

doi: 10.1016/j.ajo.2024.08.008

Further Publications

Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan

J Clin Med

Morioka M, Takamura Y, Yoshida S, Mori J, Sawada T, Matsubara H, Kusuhara S, Murakami T, Kato A, Tabuchi H, Nagasato D, Ueda T, Shimura M, Hirano T, Jujo T, Mitamura Y, Nishigaki M, Harimoto K, Sasaki M, Inatani M

doi: 10.3390/jcm14072491

Related content

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study

Short-Term Ocular Biometric Changes as Predictors of Long-Term Angle Closure Progression

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice

Long-term Safety and Performance of a Suprachoroidal Pressure Sensor System: Results of the EYEMATE-SC Trial Follow-Up Study

Association of intravitreal and topical anti-inflammatory therapies on short-term anatomical and functional outcomes following epiretinal membrane surgery

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients

Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan